Global Intramedullary Nails Market is valued approximately at USD 1.02 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.72% over the forecast period 2024-2032. In orthopedic surgery, intramedullary nails are utilized to address long bone fractures in areas like the humerus, tibia, and femur. These nails, inserted into the bone's marrow cavity, serve to stabilize and realign fractured bone fragments, promoting healing and restoring function. Typically made of metals such as titanium or stainless steel, they come in various lengths and diameters to suit different bone sizes and fracture types. Once implanted, intramedullary nails provide internal fixation, supporting the bone and creating favorable conditions for optimal healing. This method is commonly preferred for fractures that are too unstable for traditional casting or external fixation techniques. Intramedullary nailing stands as a pivotal technique in orthopedic fracture management by promoting accelerated healing, minimizing discomfort, and enabling early movement of the affected limb. Manufacturers are focusing on developing intramedullary nails using materials such as titanium alloys, which offer superior strength, biocompatibility, and corrosion resistance compared to traditional materials like stainless steel. These advanced materials offer better implant longevity and also reduce the risk of adverse reactions and complications. Accordingly, the rise in adoption of advanced materials and technologies to enhance surgical outcomes and patient experience is a key trend for the growth of the Global Intramedullary Nails Market.
The global intramedullary nails market growth is being driven by the key factors such as the rising advantages provided by intramedullary nails plating, the growing availability of a diverse range of intramedullary nails in various sizes, favorable health reimbursement policies, and an increase in the occurrence of birth deformities affecting the femur, humerus, and tibia in children. The increasing prevalence of orthopedic injuries, including fractures of long bones like femur, tibia, and humerus, is a major driving force for the intramedullary nails market. These devices are crucial in stabilizing and promoting healing in such fractures. Furthermore, the rising elderly population is expected to drive the growth of the intramedullary nails market. Additionally, the rising development of intramedullary nails that are compatible with MRI and CT scans is anticipated to further stimulate market growth throughout the forecast period. However, lack of skilled professionals, along with availability of alternative treatment options is anticipated to stifle market growth between 2022 and 2032.
The key regions considered for the global Intramedullary Nails Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to maintain its leading position in terms of market revenue in the global intramedullary nails market owing to the surge in demand of intramedullary nails, rising instances of orthopedic injuries, and a widespread acceptance of orthopedic implants. Many orthopedic trauma and reconstruction device companies have experienced positive outcomes because of supportive regulatory approvals in the region. For instance, Globus Medical, Inc., a U.S.-based firm, obtained more than eighty-two FDA product approvals. Additionally, increasing collaborations between government bodies and private associations, has significantly contributed to market expansion. For instance, In October 2021, ExsoMed Corporation, a privately held medical device firm located in the United States that specializes in orthopedic solutions for hand surgery, announced that 10,000 metacarpal fractures had been successfully treated with the INnate Intramedullary Threaded Nail. This accomplishment has been made attainable in large part by the INnate nail, which is designed for minimally invasive fixing of metacarpal fractures.
Major market player included in this report are:
B. Braun Melsungen AG (Germany)
Orthofix Holdings, Inc. (United States)
Advanced Orthopaedic Solutions (United States)
Stryker (United States)
Smith+Nephew (United Kingdom)
Aysam Ortopedi & Tibbi Cihazlar (Turkey)
Wright Medical Group N.V. (Netherlands)
Zimmer Biomet (United States)
Johnson & Johnson Inc. (United States)
Pega Medical Inc (Canada)
The detailed segments and sub-segment of the market are explained below:
By Material
Stainless Steel
Titanium
By Product Type
Upper Bone Extremities
Lower Bone Extremities
By Application
Femoral Intramedullary nail
Tibial Intramedullary Nail
Gamma Intramedullary Nail
Others
By End-user
Hospitals
Specialty clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
